Article
Cpg-Methylation-Based Risk Score Predicts Progression in Colorectal Cancer
17 Mar 2020
Abstract excerpt
Aim: To identify patients with colorectal cancer (CRC) who are at a truly higher risk of progression, which is key for individualized approaches to precision therapy. Materials & methods: We developed a predictor associated with progression-free interval (PFI) using The Cancer Genome Atlas CRC methylation data. Results: The risk score was associated with PFI in the whole cohort (p < 0.001). A nomogram consisting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
